{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:30:19Z","timestamp":1791311419466,"version":"4.3.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,27]]},"DOI":"10.1097\/tp.0000000000000031","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T13:09:53Z","timestamp":1392383393000},"page":"612-617","source":"Crossref","is-referenced-by-count":70,"title":["Antithymocyte Globulin Is Associated With a Lower Incidence of De Novo Donor-Specific Antibodies in Moderately Sensitized Renal Transplant Recipients"],"prefix":"10.1097","volume":"97","author":[{"given":"Marissa M.","family":"Brokhof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans W.","family":"Sollinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Hager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda L.","family":"Muth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Pirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet M.","family":"Bellingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Mezrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon S.","family":"Odorico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Vidyasagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixon B.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjang","family":"Djamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210129","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1681\/ASN.2012070664","article-title":"Donor-specific antibodies adversely affect kidney allograft outcomes.","volume":"23","author":"Mohan","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R2-4-20210129","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e31827d62e3","article-title":"Incidence and impact of de novo donor-specific alloantibody in primary renal allografts.","volume":"95","author":"Everly","year":"2013","journal-title":"Transplantation"},{"key":"R3-4-20210129","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/TP.0b013e3181a44206","article-title":"Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.","volume":"87","author":"Lachmann","year":"2009","journal-title":"Transplantation"},{"key":"R4-4-20210129","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"R5-4-20210129","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-6143.2007.02072.x","article-title":"Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation.","volume":"8","author":"Lefaucheur","year":"2008","journal-title":"Am J Transplant"},{"key":"R6-4-20210129","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/TP.0b013e3182139da1","article-title":"Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes.","volume":"91","author":"Cooper","year":"2011","journal-title":"Transplantation"},{"key":"R7-4-20210129","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1600-6143.2009.02800.x","article-title":"De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure.","volume":"9","author":"Hidalgo","year":"2009","journal-title":"Am J Transplant"},{"key":"R8-4-20210129","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/01.TP.0000055833.65192.3B","article-title":"Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.","volume":"75","author":"Worthington","year":"2003","journal-title":"Transplantation"},{"key":"R9-4-20210129","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-6143.2004.00360.x","article-title":"Predicting kidney graft failure by HLA antibodies: a prospective trail.","volume":"4","author":"Terasaki","year":"2004","journal-title":"Am J Transplant"},{"key":"R11-4-20210129","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/ndt\/13.3.711","article-title":"Advantages of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin.","volume":"13","author":"Thibaudin","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"R12-4-20210129","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1681\/ASN.2008101037","article-title":"Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients.","volume":"20","author":"Noel","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R13-4-20210129","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/01.TP.0000164159.20075.16","article-title":"Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways.","volume":"79","author":"Zand","year":"2005","journal-title":"Transplantation"},{"key":"R14-4-20210129","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/ajt.12068","article-title":"Pretransplant antithymocyte globulin has increased efficacy in controlling donor-reactice memory T cells in mice.","volume":"13","author":"Ayasoufi","year":"2013","journal-title":"Am J Transplant"},{"key":"R15-4-20210129","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.4049\/jimmunol.1203261","article-title":"In kidney transplant patients, alemtuzumab but not basiliximablow-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development.","volume":"191","author":"Todeschini","year":"2013","journal-title":"J Immunol"},{"key":"R16-4-20210129","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/ndt\/gfr693","article-title":"Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.","volume":"27","author":"Krystufkova","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R17-4-20210129","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2010.03210.x","article-title":"Immune reconstitution following rabbit antithymocyte globulin.","volume":"10","author":"Gurkan","year":"2010","journal-title":"Am J Transplant"},{"key":"R18-4-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/TP.0b013e31821c93bb","article-title":"Luminex-based desensitization protocols: The University of Wisconsin initial experience.","volume":"92","author":"Niederhaus","year":"2011","journal-title":"Transplantation"},{"key":"R19-4-20210129","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","article-title":"Banff 09 Meeting Report: antibody mediated graft deterioration and implementation of banff working groups.","volume":"10","author":"Sis","year":"2010","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000000031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:13:31Z","timestamp":1620976411000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201403270-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,27]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000000031","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3,27]]}}}